Tycoon Group Holdings Limited (HK:3390)
:3390
Top Page
Tycoon Group Holdings Limited
(3390)
Select Model
Select Model
Rating:53Neutral
Price Target:
HK$0.38
▲(29.66% Upside)
Action:ReiteratedDate:01/20/26
The score is held back mainly by uneven financial performance—especially weak and unstable cash generation—along with a negative P/E and no dividend data. Technicals are supportive in the near term (price above key moving averages and positive MACD), but overbought readings reduce conviction and cap the overall rating.
Positive Factors
Diversified Revenue Streams
A multi-stream business model spanning property development/leasing, advisory/asset management, and tech equity stakes reduces single-market exposure. Over 2–6 months this diversification helps stabilize cash inflows, smooth revenue volatility, and provides multiple paths to fund operations and growth.
Negative Factors
Weak and Erratic Cash Flow
Persistent negative and inconsistent operating/free cash flows undermine the firm's ability to self-fund capex, service debt, or return capital to shareholders. Over the medium term, this increases reliance on external financing, elevates refinancing risk, and constrains strategic flexibility if cash conversion issues persist.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified Revenue Streams
A multi-stream business model spanning property development/leasing, advisory/asset management, and tech equity stakes reduces single-market exposure. Over 2–6 months this diversification helps stabilize cash inflows, smooth revenue volatility, and provides multiple paths to fund operations and growth.
Read all positive factors
Tycoon Group Holdings Limited (3390) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$236.91M
Dividend Yield28%
Average Volume (3M)1.30M
Price to Earnings (P/E)―
Beta (1Y)0.02
Revenue Growth-1.68%
EPS Growth-111.10%
CountryHK
Employees258
SectorHealthcare
Sector Strength45
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)0.03
Shares Outstanding894,000,000
10 Day Avg. Volume1,126,200
30 Day Avg. Volume1,299,466
Financial Highlights & Ratios
PEG Ratio-8.80
Price to Book (P/B)5.89
Price to Sales (P/S)3.22
P/FCF Ratio-35.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Tycoon Group Holdings Limited Business Overview & Revenue Model
Company Description
Tycoon Group Holdings Limited, an investment holding company, distributes and retails a suite of health and well-being related products in Hong Kong, Mainland China, Macau, and internationally. It operates through three segments: Distribution, E-C...
How the Company Makes Money
Tycoon Group Holdings Limited generates revenue through multiple streams, primarily from its real estate operations, which include property development, leasing, and management services. The company also earns income from its financial services di...
Tycoon Group Holdings Limited Financial Statement Overview
Summary
Income Statement
55
Neutral
Balance Sheet
60
Neutral
Cash Flow
45
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 951.11M | 876.04M | 1.20B | 1.19B | 888.87M | 505.99M |
| Gross Profit | 254.05M | 232.66M | 321.10M | 243.53M | 135.01M | 71.06M |
| EBITDA | 12.58M | 35.85M | 356.41M | 82.89M | 8.91M | -49.05M |
| Net Income | -25.75M | 3.24M | 297.32M | 43.75M | -18.82M | -61.13M |
Balance Sheet | ||||||
| Total Assets | 1.24B | 1.01B | 988.95M | 1.01B | 881.46M | 619.91M |
| Cash, Cash Equivalents and Short-Term Investments | 40.81M | 34.02M | 39.10M | 74.60M | 71.63M | 119.34M |
| Total Debt | 459.43M | 330.98M | 206.16M | 341.60M | 239.08M | 198.32M |
| Total Liabilities | 711.71M | 516.61M | 445.40M | 718.96M | 620.20M | 329.47M |
| Stockholders Equity | 516.26M | 478.85M | 536.23M | 293.64M | 257.92M | 288.16M |
Cash Flow | ||||||
| Free Cash Flow | -38.49M | -78.94M | 7.97M | -64.48M | -50.11M | -119.41M |
| Operating Cash Flow | -36.74M | -76.62M | 11.86M | -63.03M | -42.20M | -107.97M |
| Investing Cash Flow | 19.52M | 48.55M | 45.70M | -9.57M | -26.25M | -74.95M |
| Financing Cash Flow | 16.46M | 25.62M | -92.36M | 68.25M | 14.33M | 247.20M |
Tycoon Group Holdings Limited Technical Analysis
Negative
0.29
Price Trends
0.30
Negative
0.29
Negative
0.31
Negative
Market Momentum
>-0.01
Negative
34.46
Neutral
72.95
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3390, the sentiment is Negative. The current price of 0.29 is above the 20-day moving average (MA) of 0.28, below the 50-day MA of 0.30, and below the 200-day MA of 0.31, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 34.46 is Neutral, neither overbought nor oversold. The STOCH value of 72.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3390.
Tycoon Group Holdings Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$606.52M | 5.13 | 16.21% | 4.94% | 17.93% | 36.82% | |
59 Neutral | HK$1.45B | 21.20 | 3.91% | ― | -15.96% | 32.95% | |
56 Neutral | HK$294.15M | -13.32 | 0.86% | 5.87% | -10.78% | -82.81% | |
54 Neutral | HK$263.57M | -2.55 | -25.22% | 3.16% | -21.31% | -149.92% | |
53 Neutral | HK$236.91M | -9.36 | -5.18% | 28.00% | -1.68% | -111.10% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
40 Underperform | HK$230.63M | 10.43 | -34.76% | ― | 6.10% | -115.12% |
* Healthcare Sector Average
HK:3390
Tycoon Group Holdings Limited
0.27
-3.19
-92.32%
HK:1110
Kingworld Medicines Group Ltd.
0.49
0.05
12.79%
HK:1518
New Century Healthcare Holding Co. Ltd.
0.54
-0.59
-52.21%
HK:1612
Vincent Medical Holdings Limited
0.92
0.52
130.00%
HK:1643
Modern Chinese Medicine Group Co. Ltd.
2.01
1.77
737.50%
HK:2393
Yestar Healthcare Holdings Co Ltd
0.10
0.02
23.75%
Tycoon Group Holdings Limited Corporate Events
Tycoon Group Renews Distribution Deal for DEEJ Products in Hong Kong
Jan 15, 2026
Tycoon Group Holdings’ indirect wholly owned subsidiary Tycoon Global has renewed its role as distributor of DEEJ-branded products in Hong Kong by entering into a new 2026 Distribution Agreement with DEEJ International, effective from 1 Janu...
Tycoon Group Eases Exclusivity, Cuts Caps on Talent Smart Transactions
Dec 19, 2025
Tycoon Group Holdings has signed a supplemental agreement with connected party Talent Smart to change Dynasty Garden’s right to distribute Talent Smart products in Hong Kong from exclusive to non‑exclusive with effect from 1 January 20...
Tycoon Group Holdings Limited Announces Auditor Change
Nov 21, 2025
Tycoon Group Holdings Limited announced a change in its auditing firm, with PricewaterhouseCoopers resigning due to a disagreement over audit fees for the year ending December 2025. Crowe (HK) CPA Limited has been appointed as the new auditor, wit...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.